Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

164 trials

NCT07753681
Recruiting
Domestication and Implementation of the PEN-Plus Clinical Model in the Zambian Health System
Not applicable · Zambia · 1 site
Registry update: 7 Aug 2026
NCT05477563
Recruiting
Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
Phase 3 · Germany, Italy, Saudi Arabia, United States · 6 sites
Registry update: 23 Mar 2026
NCT06250595
Recruiting
European Rare Blood Disorders Platform (ENROL)
Not applicable · Spain · 1 site
Registry update: 9 Feb 2024
NCT05336201
Recruiting
Cognitive Remediation Intervention to Prepare for Transition of Care
Phase 2 · United States · 1 site
Registry update: 27 Feb 2026
NCT05170412
Recruiting
Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease
Not applicable · United States · 1 site
Registry update: 18 Sept 2026
NCT05213572
Recruiting
Observational Study to Deeply Phenotype Major Organs in Sickle Cell Disease After Curative Therapies
Not applicable · United States · 1 site
Registry update: 22 Oct 2026
NCT05210114
Recruiting
Cutaneous Hydration Assessment in SCD
Not applicable · United States · 1 site
Registry update: 12 Nov 2025
NCT06213402
Recruiting
RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs)
Not applicable · Spain · 1 site
Registry update: 19 Jan 2024
NCT04819841
Recruiting
Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease
Phase 1/2 · United States · 6 sites
Registry update: 2 Jul 2026
NCT04201210
Recruiting
A Trial to Assess Haploidentical T-depleted Stem Cell Transplantation in Patients With SCD
Phase 2 · Austria, Germany · 9 sites
Registry update: 13 May 2024
NCT04657822
Recruiting
Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
Phase 4 · Belgium, Brazil, Colombia, Germany, Spain, France, Italy, Lebanon, Oman, United States · 25 sites
Registry update: 8 Jun 2026
Conflicting statuses (not updated in the registry for 5 months)
NCT04099966
Recruiting
AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
Phase 2 · United States · 1 site
Registry update: 23 Oct 2026
NCT04416178
Recruiting
Sickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders
Not applicable · United States · 1 site
Registry update: 1 May 2026
NCT07206095
Recruiting
Integrative Diagnosis for SCD and Other RADs
Not applicable · Spain · 4 sites
Registry update: 10 Nov 2026
NCT05359991
Recruiting
Exercise in Child Health
Not applicable · United States · 1 site
Registry update: 2 Oct 2026
NCT04398628
Recruiting
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Not applicable · United States · 76 sites
Registry update: 17 Aug 2026
NCT04528355
Recruiting
Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
Not applicable · United States · 1 site
Registry update: 13 Jan 2026
NCT04156893
Recruiting
RH Genotype Matched RBC Transfusions
Phase 1/2 · United States · 1 site
Registry update: 27 Apr 2026
NCT04055818
Recruiting
A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease
Phase 1 · United States · 1 site
Registry update: 30 Sept 2026
NCT04093986
Recruiting
Hydroxyurea Exposure Limiting Pregnancy and Follow-Up Lactation
Not applicable · United States · 1 site
Registry update: 18 Jun 2026

Ordered by registry start date. Freshness and sponsorship never change the order.